These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35879921)

  • 21. Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment.
    Stirton H; Meek BP; Edel AL; Solati Z; Surendran A; Aukema H; Modirrousta M; Ravandi A
    PLoS One; 2021; 16(2):e0246592. PubMed ID: 33571313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral vs. unilateral repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomized controlled trials.
    Chen JJ; Liu Z; Zhu D; Li Q; Zhang H; Huang H; Wei Y; Mu J; Yang D; Xie P
    Psychiatry Res; 2014 Sep; 219(1):51-7. PubMed ID: 24889845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Heart-Brain Connection in Depression: Can it inform a personalised approach for repetitive transcranial magnetic stimulation (rTMS) treatment?
    Michael JA; Kaur M
    Neurosci Biobehav Rev; 2021 Aug; 127():136-143. PubMed ID: 33891972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: Session-dependent efficacy: A meta-analysis.
    Teng S; Guo Z; Peng H; Xing G; Chen H; He B; McClure MA; Mu Q
    Eur Psychiatry; 2017 Mar; 41():75-84. PubMed ID: 28049085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous rTMS and psychotherapy in major depressive disorder: Clinical outcomes and predictors from a large naturalistic study.
    Donse L; Padberg F; Sack AT; Rush AJ; Arns M
    Brain Stimul; 2018; 11(2):337-345. PubMed ID: 29174304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
    Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).
    Langguth B; Wiegand R; Kharraz A; Landgrebe M; Marienhagen J; Frick U; Hajak G; Eichhammer P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):633-8. PubMed ID: 17984932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
    Kobayashi B; Cook IA; Hunter AM; Minzenberg MJ; Krantz DE; Leuchter AF
    Int Rev Psychiatry; 2017 Apr; 29(2):98-114. PubMed ID: 28362541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel method for identification of individualized resonant frequencies for treatment of Major Depressive Disorder (MDD) using repetitive Transcranial Magnetic Stimulation (rTMS): A proof-of-concept study.
    Leuchter AF; Wilson AC; Vince-Cruz N; Corlier J
    Brain Stimul; 2021; 14(5):1373-1383. PubMed ID: 34425244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of machine learning in predicting the efficacy of repetitive transcranial magnetic stimulation on treating depression based on functional and structural thalamo-prefrontal connectivity: A pilot study.
    Chen D; Lei X; Du L; Long Z
    J Psychiatr Res; 2022 Apr; 148():88-94. PubMed ID: 35121273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiating responders and non-responders to rTMS treatment for depression after one week using resting EEG connectivity measures.
    Bailey NW; Hoy KE; Rogasch NC; Thomson RH; McQueen S; Elliot D; Sullivan CM; Fulcher BD; Daskalakis ZJ; Fitzgerald PB
    J Affect Disord; 2019 Jan; 242():68-79. PubMed ID: 30172227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of repetitive transcranial magnetic stimulation (rTMS) on procedural memory and dysphoric mood in patients with major depressive disorder.
    O'Connor MG; Jerskey BA; Robertson EM; Brenninkmeyer C; Ozdemir E; Leone AP
    Cogn Behav Neurol; 2005 Dec; 18(4):223-7. PubMed ID: 16340396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Brain Functional Changes in High-Frequency Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression.
    Ozekes S; Erguzel T; Sayar GH; Tarhan N
    Clin EEG Neurosci; 2014 Oct; 45(4):257-261. PubMed ID: 24733717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder.
    Jha S; Chadda RK; Kumar N; Bal CS
    Asian J Psychiatr; 2016 Jun; 21():1-6. PubMed ID: 27208445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laterality of prefrontal hemodynamic response measured by functional near-infrared spectroscopy before and after repetitive transcranial magnetic stimulation: A potential biomarker of clinical outcome.
    Yamazaki R; Inoue Y; Matsuda Y; Kodaka F; Kitamura Y; Kita Y; Shigeta M; Kito S
    Psychiatry Res; 2022 Apr; 310():114444. PubMed ID: 35190340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of quantitative electroencephalograms following prefrontal repetitive transcranial magnetic stimulation in patients with major depression.
    Noda Y; Nakamura M; Saeki T; Inoue M; Iwanari H; Kasai K
    Neurosci Res; 2013; 77(1-2):70-7. PubMed ID: 23827366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials.
    Chen J; Zhou C; Wu B; Wang Y; Li Q; Wei Y; Yang D; Mu J; Zhu D; Zou D; Xie P
    Psychiatry Res; 2013 Dec; 210(3):1260-4. PubMed ID: 24113125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.